Jeong-im I. Sin
Chuncheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Tetrameric Biotin-Avidin Scaffold Using Anti-CD19 (FMC63) Traptavidin Fusion Enables High-Avidity CAR-T Cells for Leukemia Therapy.
Journal: Bioconjugate chemistry
Published: December 16, 2025
B16 melanomas evade antitumor immunity by the loss of epitope presentation and the acquisition of tumor resistance to granzyme B.
Journal: Cellular immunology
Published: February 15, 2021
B16 melanoma control by anti-PD-L1 requires CD8+ T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines.
Journal: Human vaccines & immunotherapeutics
Published: February 01, 2021
CD8+ T Cells Directed Against a Peptide Epitope Derived From Peptidoglycan-Associated Lipoprotein of Legionella pneumophila Confer Disease Protection.
Journal: Frontiers in immunology
Published: September 09, 2020
Optimized Gemcitabine Therapy in Combination with E7 Peptide Immunization Elicits Tumor Cure by Preventing Ag-Specific CTL Inhibition in Animals with Large Established Tumors.
Journal: DNA and cell biology
Published: September 19, 2018
Regulation of the translation activity of antigen-specific mRNA is responsible for antigen loss and tumor immune escape in a HER2-expressing tumor model.
Journal: Scientific reports
Published: July 25, 2018
Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein.
Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein.
Journal: Clinical and experimental vaccine research
Published: May 29, 2018
Therapeutic Tumor Control of HER2 DNA Vaccines Is Achieved by an Alteration of Tumor Cells and Tumor Microenvironment by Gemcitabine and Anti-Gr-1 Ab Treatment in a HER2-Expressing Tumor Model.
Journal: DNA and cell biology
Published: August 05, 2017
Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: use of protein boosting for IgG-secreting hybridoma production.
Journal: Clinical and experimental vaccine research
Published: May 26, 2017
Tumor regression is mediated via the induction of HER263-71- specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control.
Journal: Oncotarget
Published: April 24, 2016
Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 03, 2015
DNA vaccines, electroporation and their applications in cancer treatment.
Journal: Human vaccines & immunotherapeutics
Published: May 19, 2015
Last Updated: 09/26/2026